Recital 10, Regulation (EU) 2024/324

In forcesince 19 Jan 2024

For the active substances buprofezin, mepiquat and pyraclostrobin, the Authority requested the submission of additional information for the purposes of assessment of the approval criteria set out in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009, pursuant to Article 13(3a), first subparagraph, of Implementing Regulation (EU) No 844/2012. This information was submitted by the applicants within the period set by the Authority. However, additional time is needed for the Authority to evaluate the information received and adopt a conclusion on whether the active substances can be expected to meet the approval criteria and for the Commission to adopt the ensuing risk management decision.